Medical Xpress news
Medical Xpress / Study finds 90 minutes weekly activity after ablation linked to fewer atrial fibrillation relapses
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a simple, low-cost way ...
Medical Xpress / Americans prefer to screen for cervical cancer in-clinic vs. at home, finds study
American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools. While experts hope this will increase uptake in the under-screened population, a first-of-its kind study ...
Medical Xpress / Brain network identified for effective treatment of Parkinson's disease
Deep brain stimulation (DBS) improves motor symptoms of Parkinson's disease by modulating a specific brain network that is mainly active in the fast beta frequency range (20 to 35 Hz). This conclusion was reached by an interdisciplinary ...
Medical Xpress / Understanding how cancer cells use water pressure to move through the body
Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells. What makes it more dangerous is the ability of cancer cells to move quickly through the body, allowing them to invade ...
Medical Xpress / CRISPR approach turns oncogene amplification into a weakness in multiple solid tumors
The onset and aggressiveness of cancer are related to the abnormal behavior of certain genes, known as oncogenes. The best-known of these alterations is mutation, but it is not the only one. Sometimes, within a cell, a very ...
Medical Xpress / Can chemo-resistant cancer cells be resensitized?
Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged cancer cells into a state ...
Medical Xpress / Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively. The new approach could be a way to deliver treatment directly to tumors at higher doses, while ...
Medical Xpress / Why some breast cancers evade treatment: Protein secreted by T cells may explain resistant tumors
Up to 20% of hormone receptor-positive breast cancers don't respond to antiestrogen therapies. A study led by researchers at UT Southwestern, published in the Journal of Clinical Investigation, suggests that a protein secreted ...
Medical Xpress / Tiny 'mini-me' organs grown from children's cells are transforming cystic fibrosis care
When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to imagine what is happening inside their own bodies. "I tell them to picture an airport," she says. ...
Medical Xpress / Chikungunya vaccine update: Experimental adjuvant-free particles aim to prevent months of joint pain
Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. Professor Bernd Rehm, from Griffith's Institute for Biomedicine and Glycomics, ...
Medical Xpress / Nasal spray for flu prevention shows promising trial results
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials. Seasonal influenza (the flu) is an acute respiratory infection that affects up to one billion people ...
Medical Xpress / Experimental pill dramatically reduces 'bad' cholesterol
An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England ...
